Found 0 matching trials
A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies
NAThe study will evaluate safety and efficacy of a 4th generation chimeric an...
Location
Shenzhen Geno-immune Medical Institute
HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals
PHASE1This is a phase I, multi-site, study of the safety, immunologic and virolog...
Location
Whitman Walker Health Research Department (Wwh)
Updating Deep Learning Algorithms for OSA Monitoring
NAThe objective is to enhance the reliability of the algorithm to match that ...
Location
Gangnam Severance Hospital
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
PHASE1This phase I/II trial will investigate a new CD19 directed CAR-T therapy ma...
Location
Children's Hospital Colorado
Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)
PHASE1This is a Phase I, FIH, open-label, dose escalation study evaluating Safety...
Location
UCSF Medical Center- Helen Diller Family Comprehensive Cancer Center
A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
PHASE1The purposed of this study is to determine whether an infusion with special...
Location
Memorial Sloan Kettering Cancer Center
A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
PHASE1This is a Phase 1, multicenter, open-label study of CC-98633, BCMA-Targeted...
Location
Local Institution - 103
Continuous Rhythm Monitoring With Implantable Cardiac Monitors And Wearable Devices With Real-time Smartphone Alerts During AF Episodes
NAAtrial fibrillation (AF) is the most common arrhythmia affecting 1.3 millio...
Location
Oxford Univeristy Hospitals NHS Foundation Trust
Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma
PHASE1This Phase I study will test the safety and anti-myeloma activity of ascend...
Location
Center for Cancer and Blood Disorders
A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders
PHASE1The Phase Ib clinical trial is an add-on study based on combination antiret...
Location
Peking Union Medical College Hospital